Topical antiangiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative AMD.
PURPOSE: Exudative AMD (wet AMD) is treated by monthly injection into the eye of anti-VEGF proteins. VEGF is alternatively spliced to produce numerous isoforms that differ in angiogenic activity. Serine-rich protein kinase-1 (SRPK1) has been identified as a regulator of pro-angiogenic VEGF splicing...
Autors principals: | Gammons, M, Fedorov, O, Ivison, D, Du, C, Clark, T, Hopkins, C, Hagiwara, M, Dick, A, Cox, R, Harper, S, Hancox, J, Knapp, S, Bates, DO |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2013
|
Ítems similars
-
OCT angiography-based detection and quantification of the neovascular network in exudative AMD
per: Lindner, M, et al.
Publicat: (2016) -
Development of potent, selective SRPK1 inhibitors as potential topical therapeutics for neovascular eye disease
per: Batson, J, et al.
Publicat: (2017) -
Choroidal neovascularization : mechanisms of endothelial dysfunction
per: Yeo, Natalie Jia Ying, et al.
Publicat: (2021) -
Spectral domain optical coherence tomography in the treatment of myopic choroidal neovascularization
per: Fischer, MD, et al.
Publicat: (2012) -
[Spectral domain optical coherence tomography in the treatment of myopic choroidal neovascularization].
per: Fischer, MD, et al.
Publicat: (2012)